KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Regeneron Pharmaceuticals (REGN) Net Margin: 2009-2025

Historic Net Margin for Regeneron Pharmaceuticals (REGN) over the last 17 years, with Sep 2025 value amounting to 38.89%.

  • Regeneron Pharmaceuticals' Net Margin rose 286.00% to 38.89% in Q3 2025 from the same period last year, while for Sep 2025 it was 32.13%, marking a year-over-year decrease of 148.00%. This contributed to the annual value of 31.07% for FY2024, which is 93.00% up from last year.
  • According to the latest figures from Q3 2025, Regeneron Pharmaceuticals' Net Margin is 38.89%, which was up 2.72% from 37.86% recorded in Q2 2025.
  • Regeneron Pharmaceuticals' Net Margin's 5-year high stood at 1,947.00% during Q1 2022, with a 5-year trough of 22.96% in Q1 2024.
  • Its 3-year average for Net Margin is 31.57%, with a median of 30.66% in 2023.
  • Per our database at Business Quant, Regeneron Pharmaceuticals' Net Margin surged by 190,290bps in 2022 and then tumbled by 192,114bps in 2023.
  • Over the past 5 years, Regeneron Pharmaceuticals' Net Margin (Quarterly) stood at 45.01% in 2021, then surged by 115,209bps to 1,197.10% in 2022, then plummeted by 116,333bps to 33.77% in 2023, then crashed by 955bps to 24.22% in 2024, then spiked by 286bps to 38.89% in 2025.
  • Its last three reported values are 38.89% in Q3 2025, 37.86% for Q2 2025, and 26.70% during Q1 2025.